848 related articles for article (PubMed ID: 33939733)
1. Clinical determinants of the severity of COVID-19: A systematic review and meta-analysis.
Li X; Zhong X; Wang Y; Zeng X; Luo T; Liu Q
PLoS One; 2021; 16(5):e0250602. PubMed ID: 33939733
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors.
Yin T; Li Y; Ying Y; Luo Z
BMC Infect Dis; 2021 Feb; 21(1):200. PubMed ID: 33618678
[TBL] [Abstract][Full Text] [Related]
3. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis.
Figliozzi S; Masci PG; Ahmadi N; Tondi L; Koutli E; Aimo A; Stamatelopoulos K; Dimopoulos MA; Caforio ALP; Georgiopoulos G
Eur J Clin Invest; 2020 Oct; 50(10):e13362. PubMed ID: 32726868
[TBL] [Abstract][Full Text] [Related]
4. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients.
Shin EK; Choi HY; Hayes N
Epidemiol Health; 2021; 43():e2021035. PubMed ID: 33971700
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and predictors of death and severe disease in patients hospitalized due to COVID-19: A comprehensive systematic review and meta-analysis of 77 studies and 38,000 patients.
Dorjee K; Kim H; Bonomo E; Dolma R
PLoS One; 2020; 15(12):e0243191. PubMed ID: 33284825
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
Bajgain KT; Badal S; Bajgain BB; Santana MJ
Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
[TBL] [Abstract][Full Text] [Related]
7. Features of severe COVID-19: A systematic review and meta-analysis.
Del Sole F; Farcomeni A; Loffredo L; Carnevale R; Menichelli D; Vicario T; Pignatelli P; Pastori D
Eur J Clin Invest; 2020 Oct; 50(10):e13378. PubMed ID: 32860457
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis investigating the relationship between clinical features, outcomes, and severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia.
Li J; He X; Yuan Yuan ; Zhang W; Li X; Zhang Y; Li S; Guan C; Gao Z; Dong G
Am J Infect Control; 2021 Jan; 49(1):82-89. PubMed ID: 32540370
[TBL] [Abstract][Full Text] [Related]
9. Association between chronic kidney disease and COVID-19-related mortality in New York.
Mohamed NE; Benn EKT; Astha V; Okhawere KE; Korn TG; Nkemdirim W; Rambhia A; Ige OA; Funchess H; Mihalopoulos M; Meilika KN; Kyprianou N; Badani KK
World J Urol; 2021 Aug; 39(8):2987-2993. PubMed ID: 33481113
[TBL] [Abstract][Full Text] [Related]
10. The Involvement of Chronic Kidney Disease and Acute Kidney Injury in Disease Severity and Mortality in Patients with COVID-19: A Meta-Analysis.
Wang B; Luo Q; Zhang W; Yu S; Cheng X; Wang L; Chen X; Chen Y
Kidney Blood Press Res; 2021; 46(1):17-30. PubMed ID: 33352576
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcomes of patients with Corona Virus Disease 2019 (COVID-19) at Mercy Health Hospitals, Toledo, Ohio.
Khan MS; Dogra R; Miriyala LKV; Salman FNU; Ishtiaq R; Patti DK; Kumar A; Sandho G; Jacob K; Luthra K; Sharma R; Ravikumar R; Edara D; Pittampalli S; Sood D; Khatri V; Mahajan V; Avasthi S; Auoad A; Katragadda S
PLoS One; 2021; 16(4):e0250400. PubMed ID: 33886663
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of co-morbidities and their association with mortality in patients with COVID-19: A systematic review and meta-analysis.
Singh AK; Gillies CL; Singh R; Singh A; Chudasama Y; Coles B; Seidu S; Zaccardi F; Davies MJ; Khunti K
Diabetes Obes Metab; 2020 Oct; 22(10):1915-1924. PubMed ID: 32573903
[TBL] [Abstract][Full Text] [Related]
13. The Clinical Characteristics and Risk Factors of Severe COVID-19.
Hu J; Wang Y
Gerontology; 2021; 67(3):255-266. PubMed ID: 33406518
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness.
Ferastraoaru D; Hudes G; Jerschow E; Jariwala S; Karagic M; de Vos G; Rosenstreich D; Ramesh M
J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1152-1162.e3. PubMed ID: 33495097
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis.
Zhao J; Li X; Gao Y; Huang W
Int J Med Sci; 2020; 17(12):1744-1750. PubMed ID: 32714077
[TBL] [Abstract][Full Text] [Related]
16. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients.
Dessie ZG; Zewotir T
BMC Infect Dis; 2021 Aug; 21(1):855. PubMed ID: 34418980
[TBL] [Abstract][Full Text] [Related]
17. Impact and prevalence of comorbidities and complications on the severity of COVID-19 in association with age, gender, obesity, and pre-existing smoking: A meta-analysis.
Djorwé S; Bousfiha A; Nzoyikorera N; Nyandwi J; Kawthar B; Malki A
Biomedicine (Taipei); 2024; 14(1):20-38. PubMed ID: 38533301
[TBL] [Abstract][Full Text] [Related]
18. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis.
Fang X; Li S; Yu H; Wang P; Zhang Y; Chen Z; Li Y; Cheng L; Li W; Jia H; Ma X
Aging (Albany NY); 2020 Jul; 12(13):12493-12503. PubMed ID: 32658868
[TBL] [Abstract][Full Text] [Related]
19. Coronavirus disease (COVID-19): A systematic review and meta-analysis to evaluate the impact of various comorbidities on serious events.
Nandy K; Salunke A; Pathak SK; Pandey A; Doctor C; Puj K; Sharma M; Jain A; Warikoo V
Diabetes Metab Syndr; 2020; 14(5):1017-1025. PubMed ID: 32634716
[TBL] [Abstract][Full Text] [Related]
20. Variable effects of underlying diseases on the prognosis of patients with COVID-19.
Choi YJ; Park JY; Lee HS; Suh J; Song JY; Byun MK; Cho JH; Kim HJ; Park HJ
PLoS One; 2021; 16(7):e0254258. PubMed ID: 34280188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
